Prosecution Insights
Last updated: August 15, 2026

Orcosa Inc.

12 pending office actions • 9 art units • 10 examiners • 0 of 12 (0%) have an AI response strategy ready

Portfolio Summary

12
Total Pending OAs
4
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (42%)
5
Medium (42%)
2
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (42%)
§112 only1 (8%)
Double-patenting only1 (8%)
Multi-statute (no §101)5 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
92% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
8% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GONZALEZ, LUISALBERTO 3 61.2% +44.9%
REYNOLDS, STEVEN ALAN 1 65.9% +23.2%
MOU, LIYUAN 1 43.5% +57.7%
BELL, SARA ELIZABETH 1 69.1% +38.2%
ATKINSON, JOSHUA ALEXANDER 1 55.3% +34.9%
DAHLIN, HEATHER RAQUEL 1 43.0% +51.7%
KETCHAM, KAREN A 1 17.6% +32.5%
ROBINSON, MIKHAIL O'DONNEL 1 58.9% +41.5%
HOERNER, PAUL ELLSWORTH 1 50.0% +62.7%
WORSHAM, JESSICA N 1 56.4% +56.6%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18252741 IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY BELL, SARA ELIZABETH 89d overdue
18317977 USE OF CANNABINOIDS IN THE TREATMENT OF TOURETTE SYNDROME AND TIC DISORDERS MOU, LIYUAN
18252707 RAPIDLY INFUSING CANNABINOID COMPOSITIONS, PROCESSES OF MANUFACTURE, AND METHODS OF USE KETCHAM, KAREN A
18252681 RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS GONZALEZ, LUISALBERTO
18252676 RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS GONZALEZ, LUISALBERTO
18297364 STICK COMPOSITION CONTAINING CANNABINOIDS WORSHAM, JESSICA N

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18252741 IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY BELL, SARA ELIZABETH 89d overdue
18252688 RAPIDLY DISINTERGRATING COMPOSITIONS AND METHODS (Nicotine) GONZALEZ, LUISALBERTO 60d overdue
18252694 IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF ALZHEIMER'S DISEASE ROBINSON, MIKHAIL O'DONNEL 23d overdue
18252735 RAPIDLY INFUSING COMPOSITIONS WITH METHOTREXATE AND TREATMENT METHODS ATKINSON, JOSHUA ALEXANDER 21d
19272094 PACKAGING FOR RAPIDLY INFUSING COMPOSITION REYNOLDS, STEVEN ALAN
18317977 USE OF CANNABINOIDS IN THE TREATMENT OF TOURETTE SYNDROME AND TIC DISORDERS MOU, LIYUAN
18252693 METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY CONDITIONS WITH CANNABIDIOL OR ITS DERIVATIVES/ANALOGS DAHLIN, HEATHER RAQUEL
18252707 RAPIDLY INFUSING CANNABINOID COMPOSITIONS, PROCESSES OF MANUFACTURE, AND METHODS OF USE KETCHAM, KAREN A

Top Art Units

Art UnitApps
1624 3
1628 1
1625 1
1612 1
1629 1
1614 1
1627 1
1611 1
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19272094 PACKAGING FOR RAPIDLY INFUSING COMPOSITION REYNOLDS, STEVEN ALAN DP Non-Final OA Pending Jul 17, 2025
18317977 USE OF CANNABINOIDS IN THE TREATMENT OF TOURETTE SYNDROME AND TIC DISORDERS MOU, LIYUAN 1628 §103§112 Final Rejection Pending May 16, 2023
18252741 IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY BELL, SARA ELIZABETH 1625 §103§112 Final Rejection 89d overdue Pending May 12, 2023
18252735 RAPIDLY INFUSING COMPOSITIONS WITH METHOTREXATE AND TREATMENT METHODS ATKINSON, JOSHUA ALEXANDER 1612 §103Other Non-Final OA 21d Pending May 12, 2023
18252693 METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY CONDITIONS WITH CANNABIDIOL OR ITS DERIVATIVES/ANALOGS DAHLIN, HEATHER RAQUEL 1629 §103Other Final Rejection Pending May 11, 2023
18252688 RAPIDLY DISINTERGRATING COMPOSITIONS AND METHODS (Nicotine) GONZALEZ, LUISALBERTO 1624 §103Other Final Rejection 60d overdue Pending May 11, 2023
18252707 RAPIDLY INFUSING CANNABINOID COMPOSITIONS, PROCESSES OF MANUFACTURE, AND METHODS OF USE KETCHAM, KAREN A 1614 §103 Final Rejection Pending May 11, 2023
18252694 IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF ALZHEIMER'S DISEASE ROBINSON, MIKHAIL O'DONNEL 1627 §112 Non-Final OA 23d overdue Pending May 11, 2023
18252681 RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS GONZALEZ, LUISALBERTO 1624 §103§112Other Final Rejection Pending May 11, 2023
18252676 RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS GONZALEZ, LUISALBERTO 1624 §103§112Other Final Rejection Pending May 11, 2023
18307228 RAPIDLY INFUSING PLATFORM AND COMPOSITIONS FOR THERAPEUTIC TREATMENT IN HUMANS HOERNER, PAUL ELLSWORTH 1611 §103Other Final Rejection Pending Apr 26, 2023
18297364 STICK COMPOSITION CONTAINING CANNABINOIDS WORSHAM, JESSICA N 1615 §103§112 Non-Final OA Pending Apr 07, 2023

Managing Orcosa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month